@thrasher. I ama substantiatal holder and I think remuneration especially bonuses and share package for so little SHV is disgrace and management have shown are incompetent at commercialising products properly for many years. Only good deal is AstraZeneca about 6 years ago. The trials take too long and the data is not properly provided just selecting best aspects. Continuous disclose is ignored. No jealousy here.
SPL Price at posting:
74.0¢ Sentiment: None Disclosure: Held
